Integer (NYSE:ITGR) Releases Earnings Results, Beats Estimates By $0.06 EPS

Integer (NYSE:ITGR) released its quarterly earnings results on Thursday. The medical equipment provider reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06, Briefing.com reports. The company had revenue of $472.06 million during the quarter, compared to analysts’ expectations of $462.73 million. Integer had a return on equity of 12.84% and a net margin of 4.75%.The firm’s revenue was up 5.0% compared to the same quarter last year. During the same period last year, the business posted $1.43 earnings per share. Integer updated its FY 2026 guidance to 6.290-6.780 EPS.

Here are the key takeaways from Integer’s conference call:

• Integer delivered a strong FY‑2025 beat with sales up 8% reported (6% organic), adjusted EPS up 21%, expanded adjusted operating margin ~76 bps, and repurchased $50M in Q4 while announcing a ~$50M accelerated share repurchase.
• The 2026 outlook was narrowed and includes an expected 3%–4% headwind from three new products (two in electrophysiology, one in neuromodulation) that had lower‑than‑expected market adoption, driving flat to +3% organic sales guidance and near‑term margin pressure (Q1 operating margin down ~200–250 bps year‑over‑year).
• Capital and cash generation remain solid — FY‑2025 free cash flow was $105M, net total debt is ~$1.19B (3.0x trailing EBITDA), management reaffirmed disciplined capital allocation with continued M&A and buybacks and expects 2026 free cash flow of $100M–$120M.
• Management highlights a diversified, high‑value pipeline (about 40 CRM&N development customers) and expects PMA‑related customers to grow ~15%–20% CAGR over 3–5 years and aims to return to 200 bps above‑market organic growth with margin expansion by 2027, though this is forward‑looking and contingent on product launches.

Integer Price Performance

Shares of Integer stock traded up $1.93 on Thursday, hitting $88.41. The company’s stock had a trading volume of 950,466 shares, compared to its average volume of 750,851. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70. The firm has a fifty day moving average price of $82.37 and a 200-day moving average price of $88.44. Integer has a 52-week low of $62.00 and a 52-week high of $144.76. The company has a market capitalization of $3.10 billion, a P/E ratio of 36.79, a price-to-earnings-growth ratio of 0.81 and a beta of 0.77.

Wall Street Analyst Weigh In

ITGR has been the topic of a number of recent research reports. Wells Fargo & Company restated an “equal weight” rating and issued a $80.00 target price (down previously from $132.00) on shares of Integer in a research note on Friday, October 24th. Bank of America downgraded shares of Integer from a “buy” rating to a “neutral” rating and set a $87.00 price target on the stock. in a research note on Friday, October 24th. Truist Financial upped their price objective on shares of Integer from $86.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Wall Street Zen downgraded Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Finally, Argus downgraded shares of Integer from a “buy” rating to a “hold” rating in a research note on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $98.38.

Integer News Summary

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Q4 earnings beat — Integer reported $1.76 EPS vs. the Zacks/consensus $1.70 estimate and up from $1.43 a year ago, showing margin/earnings improvement. Integer (ITGR) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Revenue and full-year performance — Q4 revenue rose ~5% YoY; full-year 2025 delivered ~8% sales growth and ~21% adjusted EPS growth, which supports the bullish reaction. Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2025
• Positive Sentiment: Guidance largely in line to slightly above consensus — FY2026 EPS guidance of $6.29–$6.78 and revenue guidance of $1.8–$1.9B maintains the company’s prior outlook (management highlights keeping the midpoint of sales growth and the high end of adjusted EPS growth). That stability helped investor confidence. Integer FY2026 Guidance and Outlook
• Neutral Sentiment: Guidance nuance — the EPS range’s lower bound (6.29) is marginally below some consensus points (~6.31) while the high end is well above; investors will watch quarterly cadence and margin drivers to judge whether the company hits the high end. Integer Q4 Earnings: Key Metrics Versus Estimates
• Neutral Sentiment: Management materials available — the company posted a press release, slide deck and conference-call transcript for deeper detail; active investors should review the call/slides for margin, backlog and expected product/customer contributions. Listen to Conference Call / View Slide Deck

Integer declared that its board has initiated a stock repurchase program on Tuesday, November 4th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to reacquire up to 8.3% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s leadership believes its stock is undervalued.

Hedge Funds Weigh In On Integer

A number of institutional investors have recently modified their holdings of ITGR. Van ECK Associates Corp increased its holdings in shares of Integer by 116.9% during the 4th quarter. Van ECK Associates Corp now owns 3,095 shares of the medical equipment provider’s stock worth $243,000 after buying an additional 1,668 shares during the last quarter. Lido Advisors LLC increased its stake in Integer by 5.5% during the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after acquiring an additional 151 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Integer by 113.2% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 1,475 shares of the medical equipment provider’s stock worth $152,000 after purchasing an additional 783 shares during the period. State of Wyoming purchased a new stake in shares of Integer during the 2nd quarter worth about $233,000. Finally, Vident Advisory LLC acquired a new stake in Integer during the 2nd quarter worth approximately $218,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.